Press Release Distribution
Pricing
Customer Support
(800) 998-2927
Login
Log In
All Categories
Business
Entertainment
Health
Finance
Other
Tagged
phase-2-studies
Press Release
Oct 2, 2020
Epygenix Therapeutics Announces First Patient Enrolled in Phase 2 Study for the Treatment of Dravet Syndrome With EPX-100
Read More
Press Release
Sep 17, 2020
Epygenix Therapeutics Initiates Phase 2 Study for Dravet Syndrome With EPX-100
Read More
Press Release
Jan 27, 2020
Epygenix Therapeutics Successfully Completes EPX-100 Phase I, Placebo-Controlled, Double-Blind, 2-Period Study and Ready to Phase 2 Studies
Read More
First
Prev
1
Next
Last
